Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Neuland Laboratories Ltd banner

Neuland Laboratories Ltd
NSE:NEULANDLAB

Watchlist Manager
Neuland Laboratories Ltd Logo
Neuland Laboratories Ltd
NSE:NEULANDLAB
Watchlist
Price: 12 720 INR -2.3% Market Closed
Market Cap: ₹163.2B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
+21%
5Y
+48%
10Y
-
Investing Cash Flow
+
3Y
-168%
5Y
-190%
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-
10Y
-

Cash Flow Statement
Neuland Laboratories Ltd

Rotate your device to view
Cash Flow Statement
Currency: INR
Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024 Sep-2024 Mar-2025 Sep-2025
Operating Cash Flow
Net Income
529
819
1 053
960
822
1 092
2 157
3 539
4 014
3 759
3 463
3 141
Depreciation & Amortization
313
336
397
454
490
512
528
549
597
640
655
759
Other Non-Cash Items
270
221
4
(15)
173
216
233
135
4
(275)
(780)
(441)
Cash Taxes Paid
47
36
53
124
205
229
436
901
1 116
973
747
703
Cash Interest Paid
244
220
189
172
136
122
132
137
141
109
84
148
Change in Working Capital
(539)
(488)
439
39
(881)
(732)
(546)
(1 031)
(2 003)
(1 667)
(165)
(2 147)
Cash from Operating Activities
573
N/A
887
+55%
1 894
+113%
1 437
-24%
604
-58%
1 088
+80%
2 372
+118%
3 192
+35%
2 612
-18%
2 457
-6%
3 174
+29%
1 312
-59%
Investing Cash Flow
Capital Expenditures
(488)
(792)
(1 054)
(1 078)
(977)
(748)
(661)
(748)
(1 437)
(2 043)
(2 065)
(2 737)
Other Items
1
114
210
126
22
17
46
74
(60)
(618)
(917)
775
Cash from Investing Activities
(487)
N/A
(677)
-39%
(844)
-25%
(952)
-13%
(955)
0%
(731)
+24%
(615)
+16%
(674)
-10%
(1 497)
-122%
(2 661)
-78%
(2 982)
-12%
(1 961)
+34%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
238
90
(922)
(173)
551
(271)
(1 162)
(1 064)
(424)
(34)
513
637
Cash Paid for Dividends
(50)
(31)
(26)
(64)
(38)
(64)
(64)
(128)
(128)
(180)
(180)
(154)
Other
(244)
(220)
(189)
(172)
(136)
(122)
(132)
(137)
(141)
(109)
(84)
(148)
Cash from Financing Activities
(55)
N/A
(161)
-194%
(1 137)
-606%
(409)
+64%
377
N/A
(457)
N/A
(1 358)
-197%
(1 330)
+2%
(693)
+48%
(323)
+53%
250
N/A
335
+34%
Change in Cash
Effect of Foreign Exchange Rates
1
1
(1)
(1)
1
3
4
1
(0)
1
2
3
Net Change in Cash
33
N/A
50
+53%
(88)
N/A
75
N/A
27
-65%
(97)
N/A
403
N/A
1 190
+195%
422
-65%
(525)
N/A
444
N/A
(311)
N/A
Free Cash Flow
Free Cash Flow
85
N/A
96
+12%
840
+776%
359
-57%
(373)
N/A
341
N/A
1 711
+402%
2 444
+43%
1 175
-52%
413
-65%
1 109
+168%
(1 425)
N/A

See Also

Summary
NEULANDLAB intrinsic value, competitors valuation, and company profile.
DCF Valuation
NEULANDLAB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NEULANDLAB stock valuation using valuation multiples.
Wall Street Estimates
NEULANDLAB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NEULANDLAB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 319,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.